These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 9934368
1. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks. Ji B. Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368 [No Abstract] [Full Text] [Related]
3. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I, Cartel JL, Grosset JH. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [Abstract] [Full Text] [Related]
13. Single dose multidrug therapy for single lesion paucibacillary leprosy. Porichha D. Indian J Lepr; 1998 Sep; 70(2):213-4; author reply 219-21. PubMed ID: 9724858 [No Abstract] [Full Text] [Related]
14. Single dose multidrug therapy for single lesion paucibacillary leprosy. Prasad KN. Indian J Lepr; 1998 Sep; 70(2):215-6; author reply 219-21. PubMed ID: 9724860 [No Abstract] [Full Text] [Related]
15. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions. Ramu G. Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098 [No Abstract] [Full Text] [Related]
16. Single dose ROM therapy in Goa. Shukla P, Miranda MS, Prabhudesai R, Rege VL. Indian J Lepr; 2002 Mar; 74(2):169-72. PubMed ID: 12708738 [No Abstract] [Full Text] [Related]
17. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions. Ganapati R, Pai VV, Shroff HJ, Gandewar K. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604 [No Abstract] [Full Text] [Related]